Single low-dose primaquine for malaria control in Africa: a systematic review of safety, efficacy and implementation barriers
{{output}}
Since 2012, the WHO has recommended a single low dose of primaquine (SLDPQ, 0.25 mg/kg) alongside artemisinin-based combination therapies (ACTs) to block Plasmodium falciparum transmission and combat artemisinin resistance. Despite its proven benefits, SLDPQ a... ...
